Though land was leased out to the developer in November 2013, there is no trace of construction activity at the project site, arousing the wrath of Idco, the state's nodal agency for land acquisition and industrial infrastructure development.
The Rs 100-crore biotech-pharma-IT park being developed by Hyderabad-based Bharat Biotech International Ltd on around 65 acres of land at Andharua on the outskirts of the city.
Also Read
“Such non-responsive and non-serious attitude of the company in developing the project has been a big disappointment to Idco. I therefore urge your urgent personal intervention in the matter to meet the milestones.
As time is the essence of contract, we shall be constrained to initiate necessary action, in the event construction activities do not commence within 30 days and the milestones are not achieved as per the contract”, Idco's chairman and managing director Vishal Dev wrote to the CMD of Bharat Biotech.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
